Stay updated on Daratumumab Combo in MRD+ Myeloma Clinical Trial

Sign up to get notified when there's something new on the Daratumumab Combo in MRD+ Myeloma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Daratumumab Combo in MRD+ Myeloma Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    Page revision updated from v3.4.2 to v3.4.3.
    Difference
    0.0%
    Check dated 2026-03-11T06:34:34.000Z thumbnail image
  2. Check
    13 days ago
    Change Detected
    Summary
    Added related topics metadata: Multiple myeloma and MedlinePlus Genetics. This metadata helps with navigation and discovery without changing the study content.
    Difference
    0.1%
    Check dated 2026-03-04T02:23:55.000Z thumbnail image
  3. Check
    21 days ago
    No Change Detected
  4. Check
    28 days ago
    Change Detected
    Summary
    Added new trial sites in Detroit (Henry Ford Cancer - Detroit Brigitte Harris Cancer Pavilion), Novant Health, and Temple University Hospital Jeanes Campus. Removed existing sites including Fox Chase Cancer Center and Henry Ford Cancer Institute.
    Difference
    0.4%
    Check dated 2026-02-17T16:24:24.000Z thumbnail image
  5. Check
    35 days ago
    Change Detected
    Summary
    Added related topic links for Multiple Myeloma and MedlinePlus Genetics and updated the page revision to v3.4.1; a government funding notice was removed. The study data, endpoints, and eligibility criteria remain unchanged.
    Difference
    0.3%
    Check dated 2026-02-10T07:52:02.000Z thumbnail image
  6. Check
    42 days ago
    Change Detected
    Summary
    Updated Pittsburgh locations: added site in ZIP 15232 and removed ZIP 15323. A government funding status notice was added to the page.
    Difference
    0.4%
    Check dated 2026-02-03T03:20:41.000Z thumbnail image
  7. Check
    49 days ago
    Change Detected
    Summary
    Added glossary and new page metadata (Last Update Submitted that Met QC Criteria, Last Update Posted, No FEAR Act Data, and page Revision to v3.4.0) and removed older items (Last Update Submitted that met QC Criteria, Last Update Posted (Estimated), No FEAR Act data, and Revision: v3.3.4). To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2026-01-27T01:22:12.000Z thumbnail image

Stay in the know with updates to Daratumumab Combo in MRD+ Myeloma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Daratumumab Combo in MRD+ Myeloma Clinical Trial page.